JPH09504173A - アデノ関連ウイルスとその早期流産の診断への利用 - Google Patents
アデノ関連ウイルスとその早期流産の診断への利用Info
- Publication number
- JPH09504173A JPH09504173A JP7512424A JP51242495A JPH09504173A JP H09504173 A JPH09504173 A JP H09504173A JP 7512424 A JP7512424 A JP 7512424A JP 51242495 A JP51242495 A JP 51242495A JP H09504173 A JPH09504173 A JP H09504173A
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- aav
- october
- probe
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56983—Viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/14011—Parvoviridae
- C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
- C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Urology & Nephrology (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Saccharide Compounds (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.自然発生的流産の原因となる作用物の検出方法であって、 (a) AAVポリヌクレオチドに対するプローブを、AAV核酸のプロー ブとの間にヘテロ二本鎖を形成できる条件下で流産の結果得られた物質の試料の 核酸とハイブリダイズさせ、 (b) 前記プローブを含む二本鎖ポリヌクレオチドを検出する、各工程か らなる方法。 2.PCR,サザンブロットあるいはインサイチュハイブリダイゼーション技術 である請求の範囲第1項記載の方法。 3.プライマーpan1,pan3,nest1およびnest2からなる群か ら選択される1以上のプローブが使用されることを特徴とする請求の範囲第1項 記載の方法。 4.自然発生的流産の原因となる作用物の検出方法であって、 (a) AAV抗原に対するプローブ抗体と、流産の結果得られた物質の試 料を、抗原−抗体複合物を形成できる条件下で保温し、 (b) 前記プローブ抗体を含む抗原−抗体複合物を検出する各工程からな る方法。 5.前記プローブ抗体がA1(DSM ACC 2195,1994年10月1 3日寄託)、A20(DSM ACC 2194,1994年10月13日寄託 )、A69(DSM ACC 2196,1994年10月13日寄託)、およ び/またはB1(DSM ACC 2197,1994年10月13日寄託)で あることを特徴とする請求の範囲第4項記載の方法。 6.ELISA,RIA,FIAまたはIFAであることを特徴とする請求の範 囲第4項または第5項記載の方法。 7.自然発生的流産の原因となる作用物の検出方法であって、 (a) AAVもしくはその抗原性部分を含む試料を、抗AAV抗体を含む 疑いのある試料と、抗原−抗体複合物を形成できる条件下で保温し、 (b) 前記プローブ抗原を含む抗原−抗体複合物を検出する、各工程から なる方法。 8.前記AAVの抗原性部分がVP1,VP2またはVP3であることを特徴と する請求の範囲第7項記載の方法。 9.前記抗原−抗体複合物中の抗体がIgM型であることを特徴とする請求の範 囲第7項または第8項記載の方法。 10.ELISA,RIA,FIAまたはIFAであることを特徴とする請求の 範囲第7項ないし第9項いずれか1項記載の方法。 11.前記AAVポリヌクレオチドに対するプローブを適切なコンテナ中に含む ことを特徴とする請求の範囲第1項記載の方法を実施するためのキット。 12.前記AAV抗原に対するプローブ抗体を適切なコンテナ中に含むことを特 徴とする請求の範囲第4項記載の方法を実施するためのキット。 13.前記プローブ抗体がA1(DSM ACC 2195,1994年10月 13日寄託)、A20(DSM ACC 2194,1994年10月13日寄 託)、A69(DSM ACC 2196,1994年10月13日寄託)、お よび/またはB1(DSM ACC 2197,1994年10月13日寄託) であることを特徴とする請求の範囲第12項記載のキット。 14.AAVまたはその抗原性部分を適切なコンテナ中に含むことを特徴とする 請求の範囲第7項記載の方法を実施するためのキット。 15.前記AAVの抗原性部分がVP1,VP2および/またはVP3であるこ とを特徴とする請求の範囲第14項記載のキット。 16.AAV抗原に対する抗体。 17.前記抗体がAAVキャプシドまたはそのタンパク質に対するものであるこ とを特徴とする請求の範囲第16項記載の抗体。 18.前記抗体がA1(DSM ACC 2195,1994年10月13日寄 託)であることを特徴とする請求の範囲第17項記載の抗体。 19.前記抗体がA20(DSM ACC 2194,1994年10月13日 寄託)であることを特徴とする請求の範囲第17項記載の抗体。 20.前記抗体がA69(DSM ACC 2196,1994年10月13日 寄託)であることを特徴とする請求の範囲第17項記載の抗体。 21.前記抗体がB1(DSM ACC 2197,1994年10月13日寄 託)であることを特徴とする請求の範囲第17項記載の抗体。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT93117452.8 | 1993-10-28 | ||
EP93117452 | 1993-10-28 | ||
PCT/EP1994/003564 WO1995011997A1 (en) | 1993-10-28 | 1994-10-28 | Adeno-associated virus - its diagnostic use with early abortion |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09504173A true JPH09504173A (ja) | 1997-04-28 |
Family
ID=8213377
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7512424A Ceased JPH09504173A (ja) | 1993-10-28 | 1994-10-28 | アデノ関連ウイルスとその早期流産の診断への利用 |
Country Status (8)
Country | Link |
---|---|
US (1) | US6927281B1 (ja) |
EP (1) | EP0725837B1 (ja) |
JP (1) | JPH09504173A (ja) |
AT (1) | ATE188746T1 (ja) |
CA (1) | CA2175256A1 (ja) |
DE (1) | DE69422634T2 (ja) |
DK (1) | DK0725837T3 (ja) |
WO (1) | WO1995011997A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009519010A (ja) * | 2005-11-28 | 2009-05-14 | アイビス バイオサイエンシズ インコーポレイティッド | 外来混入ウイルスの同定に使用するための組成物 |
WO2021153659A1 (ja) * | 2020-01-31 | 2021-08-05 | Agc株式会社 | アデノ随伴ウイルス(aav)の定量方法 |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0819701A4 (en) * | 1995-03-17 | 2000-11-08 | Hisamitsu Pharmaceutical Co | MONOCLONAL ANTIBODIES SPECIFICALLY RECOGNIZING A VIRUS CAP PROTEIN ASSOCIATED WITH AN ADENOVIRUS |
EP0932694A2 (en) | 1996-09-11 | 1999-08-04 | THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES | Aav4 vector and uses thereof |
DE19738292C1 (de) * | 1997-09-02 | 1999-05-12 | Deutsches Krebsforsch | Verfahren zur Reinigung und Konzentrierung von AAV-2 sowie antigenen Teilen davon |
US6984517B1 (en) | 1998-05-28 | 2006-01-10 | The United States Of America As Represented By The Department Of Health And Human Services | AAV5 vector and uses thereof |
ES2313784T3 (es) | 1998-05-28 | 2009-03-01 | The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services | Vector aav5 y usos del mismo. |
DE19849643A1 (de) * | 1998-10-29 | 2000-05-04 | Deutsches Krebsforsch | An das AAV-Kapsid bindender, den Zelltropismus verändernder Antikörper und Verfahren zum gerichteten Gentransfer |
US7419817B2 (en) | 2002-05-17 | 2008-09-02 | The United States Of America As Represented By The Secretary Department Of Health And Human Services, Nih. | Scalable purification of AAV2, AAV4 or AAV5 using ion-exchange chromatography |
US8927269B2 (en) | 2003-05-19 | 2015-01-06 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Avian adenoassociated virus and uses thereof |
US8097416B2 (en) | 2003-09-11 | 2012-01-17 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
US8546082B2 (en) | 2003-09-11 | 2013-10-01 | Ibis Biosciences, Inc. | Methods for identification of sepsis-causing bacteria |
US20120122102A1 (en) | 2003-09-11 | 2012-05-17 | Rangarajan Sampath | Compositions for use in identification of bacteria |
US8137960B2 (en) | 2003-12-04 | 2012-03-20 | The United States Of America As Represented By The Department Of Health And Human Services | Bovine adeno-associated viral (BAAV) vector and uses thereof |
WO2006119432A2 (en) | 2005-04-29 | 2006-11-09 | The Government Of The U.S.A., As Rep. By The Sec., Dept. Of Health & Human Services | Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5436146A (en) * | 1989-09-07 | 1995-07-25 | The Trustees Of Princeton University | Helper-free stocks of recombinant adeno-associated virus vectors |
NL8902301A (nl) * | 1989-09-14 | 1991-04-02 | Rijksuniversiteit | Humaan parvovirus b19 eiwitten, hun produktie en hun gebruik in diagnostische assays en vaccins. |
DE4003826C2 (de) | 1990-02-08 | 1995-11-23 | Mikrogen Molekularbiol Entw | Peptide der Kapsidproteine VP1 oder VP2 des Parvovirus B19 |
EP0819701A4 (en) * | 1995-03-17 | 2000-11-08 | Hisamitsu Pharmaceutical Co | MONOCLONAL ANTIBODIES SPECIFICALLY RECOGNIZING A VIRUS CAP PROTEIN ASSOCIATED WITH AN ADENOVIRUS |
-
1994
- 1994-10-28 DK DK94931006T patent/DK0725837T3/da active
- 1994-10-28 CA CA002175256A patent/CA2175256A1/en not_active Abandoned
- 1994-10-28 JP JP7512424A patent/JPH09504173A/ja not_active Ceased
- 1994-10-28 US US08/637,752 patent/US6927281B1/en not_active Expired - Fee Related
- 1994-10-28 DE DE69422634T patent/DE69422634T2/de not_active Expired - Fee Related
- 1994-10-28 EP EP94931006A patent/EP0725837B1/en not_active Expired - Lifetime
- 1994-10-28 AT AT94931006T patent/ATE188746T1/de not_active IP Right Cessation
- 1994-10-28 WO PCT/EP1994/003564 patent/WO1995011997A1/en active Application Filing
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009519010A (ja) * | 2005-11-28 | 2009-05-14 | アイビス バイオサイエンシズ インコーポレイティッド | 外来混入ウイルスの同定に使用するための組成物 |
WO2021153659A1 (ja) * | 2020-01-31 | 2021-08-05 | Agc株式会社 | アデノ随伴ウイルス(aav)の定量方法 |
Also Published As
Publication number | Publication date |
---|---|
WO1995011997A1 (en) | 1995-05-04 |
ATE188746T1 (de) | 2000-01-15 |
DE69422634T2 (de) | 2000-07-27 |
CA2175256A1 (en) | 1995-05-04 |
EP0725837A1 (en) | 1996-08-14 |
DK0725837T3 (da) | 2000-06-13 |
US6927281B1 (en) | 2005-08-09 |
EP0725837B1 (en) | 2000-01-12 |
DE69422634D1 (de) | 2000-02-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4753873A (en) | Peptides for the diagnosis of HTLV-III antibodies, their preparation and use | |
EP0233045A2 (en) | Peptides for the diagnose of HTLV-III antibodies, their preparation and use | |
JPH09504173A (ja) | アデノ関連ウイルスとその早期流産の診断への利用 | |
KR101652962B1 (ko) | 돼지열병 바이러스 생마커백신주 접종 돼지와 돼지열병 바이러스 야외주 감염 돼지의 항체 감별용 키트 및 이를 이용한 감별방법 | |
KR100730529B1 (ko) | Hcv 코어 항원의 검출 또는 정량 방법 및 이에사용하기 위한 검출 또는 정량용 시약 | |
US20080254440A1 (en) | Anti-Sars Virus Antibody, Hybridoma Producing the Antibody and Immunoassay Reagent Using the Antibody | |
JP2001505778A (ja) | HIV感染の初期の検出のための未変性の(non―dentured)HIV抗原を使用する新規のEIA試験 | |
JP6080850B2 (ja) | 改善されたワクチン診断法 | |
WO2001032908A1 (fr) | Anticorps monoclonal, hybridome, immunoessai et necessaire a diagnostic | |
JP2001041961A (ja) | HIV−1p24抗原の免疫測定方法及び試薬 | |
Collins et al. | A competition ELISA for the detection of antibodies to rabbit haemorrhagic disease virus | |
US10634676B2 (en) | Method and kit for simultaneously detecting human parvovirus B19 antigen and antibody | |
JP3987430B2 (ja) | ノーウォークウイルスに対する抗体及びこの抗体を用いたウイルスの検出方法 | |
CN115151824A (zh) | SARS-CoV-2病毒的检测方法及检测试剂盒 | |
CA2272924A1 (en) | A whole blood/mitogen assay for the early detection of a subject with cancer and kit | |
RU2133472C1 (ru) | Способ диагностики активной стадии цитомегаловирусной инфекции человека | |
KR100430935B1 (ko) | 대장균 발현 재조합 3abc 비구조단백질 및단클론항체를 이용한 구제역 진단방법 | |
Morinet et al. | The use of labeled fusion protein for detection of B19 parvovirus IgM antibodies by an immunocapture test | |
WO2022244861A1 (ja) | 抗ノロウイルス抗体 | |
JP3504633B2 (ja) | ヘリコバクター・ピロリへの感染を判定する検査方法及び検査試薬 | |
WO2022244862A1 (ja) | ノロウイルスの免疫測定方法及び免疫測定器具 | |
US5445932A (en) | Method for detection of a new marker associated with hepatitis delta virus infection | |
CN116041449A (zh) | 一种新型冠状病毒抗体检测试剂盒 | |
MXPA96004079A (en) | Homogeneous trial of genetic probes with a receiver directed against the brand | |
TW202306977A (zh) | 抗諾羅病毒抗體 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20031224 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040216 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040309 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050315 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050615 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050822 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050815 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20060606 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20061023 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20061128 |